- Company Overview for NUCLEOME THERAPEUTICS LIMITED (12109297)
- Filing history for NUCLEOME THERAPEUTICS LIMITED (12109297)
- People for NUCLEOME THERAPEUTICS LIMITED (12109297)
- More for NUCLEOME THERAPEUTICS LIMITED (12109297)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
25 Nov 2022 | RP04AP03 | Second filing for the appointment of Phil Boyd as a secretary | |
14 Nov 2022 | SH02 | Sub-division of shares on 21 October 2022 | |
14 Nov 2022 | SH08 | Change of share class name or designation | |
14 Nov 2022 | SH10 | Particulars of variation of rights attached to shares | |
04 Nov 2022 | SH01 |
Statement of capital following an allotment of shares on 21 October 2022
|
|
01 Nov 2022 | RP04AP01 | Second filing for the appointment of Rana Al-Hallaq as a director | |
01 Nov 2022 | RP04AP01 | Second filing for the appointment of Dr Fiona Caroline Maclaughlin as a director | |
01 Nov 2022 | RP04AP01 | Second filing for the appointment of Bauke Anninga as a director | |
26 Oct 2022 | AP01 |
Appointment of Rana Al-Hallaq as a director on 11 October 2022
|
|
26 Oct 2022 | RESOLUTIONS |
Resolutions
|
|
26 Oct 2022 | MA | Memorandum and Articles of Association | |
25 Oct 2022 | PSC05 |
Change of details for Oxford Science Enterprises Plc as a person with significant control on 11 October 2022
|
|
25 Oct 2022 | AP01 |
Appointment of Dr Fiona Caroline Maclaughlin as a director on 11 October 2022
|
|
25 Oct 2022 | AP01 |
Appointment of Bauke Anninga as a director on 11 October 2022
|
|
25 Oct 2022 | AP03 |
Appointment of Phil Boyd as a secretary on 11 October 2022
|
|
21 Oct 2022 | AD01 | Registered office address changed from Bioescalator Innovation Building University of Oxford Old Road Campus, Roosevelt Dr Oxford OX3 7FZ United Kingdom to Suite C, Second Floor, Schrodinger Building, Oxford Science Park Oxford OX4 4GE on 21 October 2022 | |
29 Jul 2022 | CS01 | Confirmation statement made on 29 July 2022 with updates | |
28 Jul 2022 | SH01 |
Statement of capital following an allotment of shares on 29 June 2022
|
|
22 Dec 2021 | AA | Accounts for a small company made up to 31 July 2021 | |
28 Oct 2021 | PSC05 | Change of details for Oxford Sciences Innovation Plc as a person with significant control on 30 September 2021 | |
21 Jul 2021 | CS01 | Confirmation statement made on 16 July 2021 with no updates | |
23 Mar 2021 | CH01 | Director's details changed for Dr Danuta Mariola Jeziorska on 28 August 2019 | |
18 Jan 2021 | AA | Total exemption full accounts made up to 31 July 2020 | |
17 Dec 2020 | AP01 | Appointment of Mr Jonathan Paul Hepple as a director on 30 November 2020 | |
17 Dec 2020 | CH01 | Director's details changed for Dr Danuta Mariola Jeziorska on 30 July 2020 |